Phase II trial of gefitinib plus pemetrexed after the relapse to gefitinib in the patients with non-small-cell lung cancer harboring EGFR gene mutations.
Phase of Trial: Phase II
Latest Information Update: 27 Jun 2014
At a glance
- Drugs Gefitinib (Primary) ; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 15 May 2013 New trial record